TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
JAZZ

Jazz Pharmaceuticals PLC

Healthcare · Biotechnology

236.30$ +0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow JAZZ
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – +157.5% +64.7% +13.6% +43.1% +31.1% +11.0% +17.4% +15.3% -2.8% +15.9% -13.5% +63.4% -14.1% +27.8% -2.9%
– +89.6% +2.1% +42.8% -39.5% -4.2% -10.1% +848.4% +10.6% +62.8% -19.2% +5.3% +45.2% +31.2% +70.8% -24.8% +98.6% +13.9% +1.5% +3.3% +5.5%
– – – +33.8% -26.5% +38.0% +151.9% +11.1% +93.6% +56.3% +31.5% +7.9% +8.2% -4.2% +7.9% +9.4% +56.2% +17.5% +2.2% +9.3% +17.4%
– – – – – – – -696.2% – +9.1% -10.4% -7.9% -281.2% – -114.1% – +288.9% -77.0% – – –
– +440.5% +78.6% -92.4% -1,247.0% – – – – – – – – -13.0% -744.5% – – – -2,164.0% – –
– +19.0% +87.2% +812.6% -78.9% -21.8% +22.2% +288.9% -49.8% +2,019.3% -85.0% +405.0% -37.2% +15.4% +38.7% +108.0% -88.0% +994.2% -95.2% +100.6% +336.3%
– -99.0% – -323.8% -48.7% -65.0% +3,690.6% +386.6% -97.1% +9,368.3% -99.8% +77,474.3% -84.6% +46.7% -60.6% +548.9% +417.2% -91.4% -63.5% +211.7% +197.1%
– – – – – – – – – – – – – – – +72.4% 0.0% -1.6% – – –
– – – -93.5% +0.0% +875.0% -73.7% -254.3% +439.5% -69.1% +45.8% +352.1% -64.5% +430.0% -42.4% -51.4% -75.7% -99.8% +499,457.4% +15.4% -59.9%
– – – – – – – – -80.1% +911.1% -118.9% – -140.0% -90.2% +3.9% – +554.1% -115.0% -94.7% – -308.4%
– -39.2% -14.9% -35.7% -80.2% -316.8% +20.2% – -105.4% – -130.1% – -175.6% +17.1% -38.7% – +651.9% -113.3% -42.3% – -4,357.1%
– – -58.9% -425.2% – – +27.7% +718.4% -18.3% -80.9% +541.1% -304.4% – -480.7% – +28.3% -210.9% – +115.4% +45.1% -212.6%
– – – – – – +169.3% +55.9% +19.8% -38.8% +197.4% -17.5% +41.6% +15.2% -11.0% -12.4% +40.9% +5.6% +38.0% +26.2% -15.0%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?